Abstract
Background: Periodontitis is a multifactorial infectious disease that affects a large population worldwide. Oral microorganisms and susceptible host have been proposed to be the prerequisite for the development of periodontitis. Recently, the involvement of epigenetic modifications in the development of periodontitis has been suggested.
Objectives: This review aims to detail recent discoveries involving the epigenetic alterations in periodontitis, and discuss the possible epigenetic mechanisms contributing to the expression of periodontitis- related genes.
Conclusions: The expression of inflammatory cytokines during periodontitis is regulated at epigenetic level by mechanisms such as DNA methylation, histone modification and miRNAs. In addition, periodontal pathogens and their virulence factors could induce epigenetic alterations of periodontal tissues, and thus affect the progression and prognosis of periodontitis. The involvement of epigenetic modifications during periodontitis not only advances our knowledge on the pathogenesis of periodontitis, but may also lead to the identification of potential therapeutic targets of this oral disease.
Keywords: Periodontitis, epigenetics, DNA methylation, histone modification, microRNA, epigenetic regulation.
Current Stem Cell Research & Therapy
Title:Epigenetic Regulations in the Pathogenesis of Periodontitis
Volume: 13 Issue: 2
Author(s): Yu Luo, Xian Peng, Dingyu Duan, Chengcheng Liu, Xin Xu*Xuedong Zhou*
Affiliation:
- State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu,China
- State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu,China
Keywords: Periodontitis, epigenetics, DNA methylation, histone modification, microRNA, epigenetic regulation.
Abstract: Background: Periodontitis is a multifactorial infectious disease that affects a large population worldwide. Oral microorganisms and susceptible host have been proposed to be the prerequisite for the development of periodontitis. Recently, the involvement of epigenetic modifications in the development of periodontitis has been suggested.
Objectives: This review aims to detail recent discoveries involving the epigenetic alterations in periodontitis, and discuss the possible epigenetic mechanisms contributing to the expression of periodontitis- related genes.
Conclusions: The expression of inflammatory cytokines during periodontitis is regulated at epigenetic level by mechanisms such as DNA methylation, histone modification and miRNAs. In addition, periodontal pathogens and their virulence factors could induce epigenetic alterations of periodontal tissues, and thus affect the progression and prognosis of periodontitis. The involvement of epigenetic modifications during periodontitis not only advances our knowledge on the pathogenesis of periodontitis, but may also lead to the identification of potential therapeutic targets of this oral disease.
Export Options
About this article
Cite this article as:
Luo Yu, Peng Xian , Duan Dingyu , Liu Chengcheng , Xu Xin *, Zhou Xuedong*, Epigenetic Regulations in the Pathogenesis of Periodontitis, Current Stem Cell Research & Therapy 2018; 13 (2) . https://dx.doi.org/10.2174/1574888X12666170718161740
DOI https://dx.doi.org/10.2174/1574888X12666170718161740 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Inhibition of Human Leucocyte Elastase by Novel Thieno-1,3-oxazin-4-ones and Thieno-1,3-thioxazin-4-ones
Letters in Drug Design & Discovery Use of Anti-Infective Drugs in Rheumatology
Anti-Infective Agents in Medicinal Chemistry ADAM17 as a Therapeutic Target in Multiple Diseases
Current Pharmaceutical Design Behcets Syndrome: Literature Review
Current Rheumatology Reviews Is uPAR the Centre of a Sensing System Involved in the Regulation of Inflammation?
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Vaccines and Photodynamic Therapies for Oral Microbial-Related Diseases
Current Drug Metabolism Modulation of Matrix Metalloproteinases by Plant-derived Products
Current Cancer Drug Targets Quercetin Decreased Alveolar Bone Loss and Apoptosis in Experimentally Induced Periodontitis Model in Wistar Rats
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Commercially Available, FDA-approved Epigenetic Modifiers As Therapeutic Agents in Bacterial Infection
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Protein Interaction Domains: Structural Features and Drug Discovery Applications (Part 2)
Current Medicinal Chemistry Highlights in Peptide Nanoparticle Carriers Intended to Oral Diseases
Current Topics in Medicinal Chemistry Healing or Not Healing
Current Pharmaceutical Biotechnology Unveiling the Anti-tubercular Properties of Biscoumarins, through Biological Evaluation and Docking Studies
Letters in Drug Design & Discovery Nanofibers: New Insights for Drug Delivery and Tissue Engineering
Current Topics in Medicinal Chemistry <i>Uncaria tomentosa</i> (Willd. ex Schult.): Focus on Nutraceutical Aspects
Current Bioactive Compounds Recent Patents on Antibacterial, Antifungal and Antiviral Properties of Tea
Recent Patents on Anti-Infective Drug Discovery SPR Imaging Biosensor for Aspartyl Cathepsins: Sensor Development and Application for Biological Material
Protein & Peptide Letters Evaluation of Salivary Melatonin Levels in HIV-positive Patients: A Historical Cohort Study
Reviews on Recent Clinical Trials Phytochemicals as Inhibitors of Candida Biofilm
Current Pharmaceutical Design L9 Orthogonal Design Assisted Formulation and Evaluation of Chitosanbased Buccoadhesive Films of Miconazole Nitrate
Current Drug Delivery